To: Gordan_Gecko_III who wrote (11 ) 8/3/2000 9:03:25 AM From: Kip518 Read Replies (1) | Respond to of 326 August 03, 2000 08:46 Healtheon/WebMD, Medical Manager and CareInsite Set Record Dates and Stockholder Meeting Dates for Merger Approval ATLANTA, Ga., and ELMWOOD PARK, N.J., Aug. 3 /PRNewswire/ -- Healtheon/WebMD Corporation (Nasdaq: HLTH), Medical Manager Corporation (Nasdaq: MMGR), and CareInsite, Inc. (Nasdaq: CARI) today announced that Healtheon/WebMD's Registration Statement on Form S-4 has been declared effective by the Securities and Exchange Commission. The Registration Statement relates to the proposed merger transactions between Healtheon/WebMD, Medical Manager and CareInsite and contains the joint proxy statement/prospectus for the transactions. The Boards of Directors of all companies have established August 3, 2000 as the record date. Healtheon/WebMD will hold its annual meeting of stockholders on September 12, 2000 at 9:30 am, Eastern time, at the law offices Alston & Bird LLP, One Atlantic Center, The Gaines Room, 42nd Floor, 1201 West Peachtree Street, Atlanta, Georgia 30309-3424, to vote on the proposed transactions and other proposals. Medical Manager will hold a special meeting of its stockholders on September 12, 2000 at 9:30 am, Eastern time, at the St. Regis Hotel, Two East 55th Street, New York, New York 10022. CareInsite will hold a special meeting of its stockholders on September 12, 2000 at 10:00 am, Eastern time, at the St. Regis Hotel, Two East 55th Street, New York, New York 10022. Along with stockholder approval, the Healtheon/WebMD merger with Medical Manager and CareInsite is subject to regulatory review by the Federal Trade Commission and the Antitrust Division of the United States Department of Justice. The companies substantially complied with the second request for information by the Department of Justice on July 28, 2000. The final waiting period will expire at 11:59 pm on August 17, 2000 and may be extended only by court order or consent of the parties. Subject to receipt of regulatory and stockholder approval, consummation of the transactions is anticipated to occur shortly after the stockholders' meetings of all three companies, after which the company will operate under the corporate name of WebMD.